Category: Non-Research (Evidence Based Practice or Quality Improvement)
The use of gastric point-of-care ultrasound (POCUS) for surgical patients receiving Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists to assess residual gastric content.
The use of GLP-1s to combat obesity and type 2 diabetes mellitus has created a challenge to CRNAs by potentially increasing aspiration risk for surgical patients due to delayed gastric emptying.
